EVERSANA

EVERSANA® is a leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com.

neopharma

Neopharma is one of the largest pharmaceutical companies in MENA region with 100% subsidiaries in USA, Japan, Brazil, UK and India. A vertically integrated business, comprising of Key intermediaries, API, R&D and Formulation facilities in regulated and emerging markets. Our global presence is supported by 10 manufacturing facilities spread across 3 continents delivering a wide range of branded & generic formulations, and active pharmaceutical ingredients (APIs). The therapeutic segments covered are acute and chronic therapies and having strong foot hold in anti-infective segment. Neopharma is primarily focusing on novel therapeutics, increasing portfolio depth and debilitating diseases at affordable prices.

CEVA SANTE ANIMALE

Ceva Santé Animale (Ceva) is the 5th global animal health company, led by experienced veterinarians, whose mission is to provide innovative health solutions for all animals to ensure the highest level of care and well-being. Our portfolio includes preventive medicine such as vaccines and animal welfare products, pharmaceutical solutions for farm and companion animals, as well as equipment and services to provide the best experience for our customers. With more than 7,000 employees located in 47 countries, Ceva strives daily to bring to life its vision as a One Health company: “Together, beyond animal health”. Our 21 R&D centers and 33 production sites worldwide attest to our commitment to research and the development of increasingly innovative solutions.  2024 turnover: €1.77 billion.

unimed unihealth group

UniMed UniHealth began its journey in the year 1997 in Bangladesh by introducing life-saving and innovative pharmaceutical products from world class pharmaceutical companies like Grunenthal, Biotest, Abbott, Janssen and Vifor. A team of dedicated professionals having experience in multinational and leading local pharmaceutical companies under the leadership of Mr M Mosaddek Hossain prepared the plan, determined the strategies and progressed to develop the organization. Within a short period of time, the organization could successfully introduce a number of new chemical entities (NCEs) providing improved benefits to the patients. The development of manufacturing capabilities in the year 2000 allowed introduction of a large number of branded generics in a number of specialty therapeutic areas. UniMed UniHealth ensured highest quality products from the beginning through procurement of active ingredients and excipients from selected and controlled sources, systematically processing in well designed and equipped facilities in compliance to regulatory requirements maintaining cGMP, GLP and ISO standards. UniMed UniHealth organized professional marketing with focused promotion through dedicated well trained teams and supplied the products throughout the country with its own developed distribution network. UniMed UniHealth believes and adheres to values like Quality, Knowledge and Responsibility in all aspects of its operation and earned respect and recognition of its valued customers in the healthcare sector of Bangladesh.

Alembic Pharmaceuticals Limited

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.